Comparing the current results to its competitors, Iridex reported Revenue decrease in the 2 quarter 2026 year on year by -0.91 %, despite the revenue increase by the most of its competitors of 13.48 %, recorded in the same quarter.
December 18, 2024
The management of glaucoma, a leading cause of irreversible blindness worldwide, has reached a new horizon with the announcement from Iridex Corporation regarding a groundbreaking five-year study on MicroPulse Transscleral Laser Therapy (TLT), also known as Transscleral Cyclophotocoagulation. This study, recently published in the esteemed journal Ophthalmology Therapy , underscores both the long-term effectiveness and safety of MicroPulse TLT, solidifying its role as a viable treatment option for patients suffering from various forms of glaucoma, including both primary and secondary types.Conducted by Dr. Ronald de Crom and his esteemed colleagues at the University Eye Clinic Maastricht, Netherlands, this l...
January 11, 2024
Celebrating 35 Years of Laser Innovation: Iridex Introduces Next-Generation Lasers for Retina Disorders and Glaucoma Treatment in the US MarketMOUNTAIN VIEW, Calif., Jan. 11, 2024 - Iridex Corporation, a renowned global leader in laser-based medical systems for eye diseases, has proudly announced the launch of its state-of-the-art Iridex 532 and Iridex 577 Lasers in the US market. This milestone coincides with the company s 35th anniversary, adding further excitement to their commitment in advancing retina disorder and glaucoma treatment. The announcement was made just days before the official unveiling at the highly anticipated Hawaiian Eye and Retina 2024 Meeting, scheduled from January 13th to 19th.The i...
Bausch Health Companies Inc operates through three segments: Bausch + Lomb/International, Salix, and Ortho Dermatologics. The company focuses on developing, manufacturing, and marketing a wide range of pharmaceutical products, medical devices, and over-the-counter products primarily in the areas of eye health, gastroenterology, and dermatology. Bausch Health aims to provide innovative and quality healthcare solutions to improve patients' lives globally.
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Allurion Technologies Inc is a medical device company that specializes in developing non-surgical solutions for weight loss. Their business model is centered around providing a comprehensive weight loss program that combines their innovative medical device, the Elipse Balloon, with personalized coaching and support. They target individuals seeking a non-invasive and convenient approach to achieving their weight loss goals.
AbbVie Inc operates primarily as a global biopharmaceutical company, focusing on the research, development, manufacturing, and commercialization of advanced therapies and medications in critical areas such as immunology, oncology, neuroscience, and virology. The company aims to improve patient outcomes and address unmet medical needs by leveraging its scientific expertise and capabilities while providing value to stakeholders in the healthcare industry.
Zynex Inc's business model revolves around the development and distribution of medical devices and software that provide non-invasive electrotherapy for pain management and rehabilitation.
Sources:
Iridex Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Iridex Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
